Longitude Venture Partners III, L.P.
10% Owner

Longitude Venture Partners III, L.P. insider trades: Inozyme Pharma (INZY) stock buys and sales

10% Owner, Inozyme Pharma Last trade Apr 19, 2022 15 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2018
6
Companies
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Longitude Venture Partners III, L.P. reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 19, 2022INZY↑ Buy$5.0M
Feb 2, 2022SRRA↑ Buy$4.7M
May 11, 2021TALS↑ Buy$4.0M
Aug 28, 2020MTEM↓ Sell$38K
Jul 28, 2020INZY↑ Buy$10.0M
Jul 10, 2020ETNB↑ Buy$3.0M
Nov 25, 2019MTEM↑ Buy$7.5M
Nov 11, 2019ETNB↑ Buy$9.2M
Nov 2, 2018AXNX↑ Buy$8.0M
Sep 21, 2018MTEM↑ Buy$2.0M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Longitude Venture Partners III, L.P.'s insider trades

Longitude Venture Partners III, L.P. is a 10% owner of Inozyme Pharma (INZY). Since Sep 21, 2018, it has reported 9 open-market purchases worth $53.4M and 1 sale worth $38K on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include conversions (5 filings), other transactions (3 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every INZY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.